deoxyglucose has been researched along with Cancer of Prostate in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (34.62) | 18.2507 |
| 2000's | 6 (23.08) | 29.6817 |
| 2010's | 11 (42.31) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, MP; Lin, YR; Tang, P; Xie, KJ; Zhou, P | 1 |
| Babaie, E; Engedal, N; Guldvik, IJ; Hohloch, J; Itkonen, HM; Luhr, M; Mills, IG; Minner, S; Schlomm, T; Tsourlakis, MC | 1 |
| Fath, MA; Li, L; Scarbrough, PM; Spitz, DR; Watson, WH | 1 |
| Mansilla, S; Portugal, J; Priebe, W; Rodríguez-Sánchez, MA; Vizcaíno, C | 1 |
| Jeon, JY; Kim, SW; Park, KC; Yun, M | 1 |
| Beaudoin, B; Bray, K; DiPaola, RS; Doram, D; Dvorzhinski, D; Foran, DJ; Garikapaty, V; Karp, C; Mathew, R; May, M; Stein, M; Thalasila, A; White, E | 1 |
| Foster, PA; Leese, MP; Newman, SP; Potter, BV; Purohit, A; Reed, MJ; Tagg, SL | 1 |
| Auberger, P; Ben Sahra, I; Bertolotto, C; Bost, F; Cormont, M; Deckert, M; Giorgetti-Peraldi, S; Giuliano, S; Gounon, P; Larbret, F; Laurent, K; Le Marchand-Brustel, Y; Ponzio, G; Tanti, JF | 1 |
| Andreesen, R; Gottfried, E; Hartmannsgruber, G; Kreutz, M; Kunz-Schughart, LA; Peter, K; Peuker, A; Reichle, A; Rogenhofer, S; Waibel, H; Wehrstein, M | 1 |
| Ben Sahra, I; Bost, F; Tanti, JF | 1 |
| Bray, K; Dipaola, RS; Dvorzhinski, D; Eddy, S; Goodin, S; Gounder, M; Jeyamohan, C; Lin, H; Stein, M; White, E | 1 |
| Anderson, KM; Guinan, P; Rubenstein, M | 1 |
| Chen, CS; Huang, TH; Kuo, YC; Lai, IL; Lin, HY; Lin, SP; Niu, DM; Weng, YI | 1 |
| Dunkel, L; Erkkilä, K; Parvinen, M; Suomalainen, L; Wikström, M | 1 |
| Jensen, CA; Loening, SA; Moseley, PL; Roigas, J; Wallen, ES; Wharton, W | 1 |
| Adams, JL; Franklin, RB; Matheson, BK; Patel, R; Zou, J | 1 |
| Abdalla, MY; Ahmad, IM; Aykin-Burns, N; Domann, FE; Oberley, LW; Simons, AL; Spitz, DR | 1 |
| Altmann, A; Bellemann, ME; Blatter, J; Haberkorn, U; Kahn, B; Morr, I; Oberdorfer, F; van Kaick, G | 1 |
| Bares, R; Büll, U; Effert, PJ; Handt, S; Jakse, G; Wolff, JM | 1 |
| Gross, MD; Grossman, HB; Shreve, PD; Wahl, RL | 1 |
| Finn, RD; Garza, D; Goldsmith, SJ; Horowitz, SM; Imbriaco, M; Kalaigian, H; Larson, SM; Reddy, D; Scher, HI; Yeh, SD; Zhang, JJ | 1 |
| Ide, M; Shohtsu, A; Takagi, S; Yasuda, S | 1 |
| Altmann, A; Berger, MR; Haag, D; Haberkorn, U; Oberdorfer, F; Peschke, P; Trojan, H; van Kaick, G; Ziegler, SI | 1 |
| Altmann, A; Bellemann, ME; Blatter, J; Brix, G; Doll, J; Gerlach, L; Haberkorn, U; Morr, I; Oberdorfer, F; van Kaick, G | 1 |
| Agus, DB; Ballangrud, A; Cordon-Cardo, C; Golde, DW; Scher, HI; Sgouros, G | 1 |
| Ackermann, R; Gerharz, CD; Heicappell, R; Müller-Gärtner, H; Müller-Mattheis, V; Reinhardt, M; Vosberg, H | 1 |
3 trial(s) available for deoxyglucose and Cancer of Prostate
| Article | Year |
|---|---|
Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Deoxyglucose; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Patient Selection; Positron-Emission Tomography; Prostatic Neoplasms; Uterine Cervical Neoplasms | 2010 |
Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose.
Topics: Antimetabolites; Deoxyglucose; Fluorine Radioisotopes; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Tomography, Emission-Computed | 1996 |
Detection of bony metastases of androgen-independent prostate cancer by PET-FDG.
Topics: Aged; Androgens; Bone Neoplasms; Deoxyglucose; Evaluation Studies as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 1996 |
23 other study(ies) available for deoxyglucose and Cancer of Prostate
| Article | Year |
|---|---|
[2-deoxyglucose enhances chemosensitivity of androgen-independent prostate cancer cells to docetaxel].
Topics: Androgens; Cell Line, Tumor; Deoxyglucose; Docetaxel; Drug Resistance, Neoplasm; HSP70 Heat-Shock Proteins; Humans; Male; Prostatic Neoplasms; Taxoids; Ubiquitinated Proteins | 2013 |
UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation.
Topics: Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Endoplasmic Reticulum; Galactosyltransferases; Glycosylation; Humans; Male; Prostatic Neoplasms; Receptors, Androgen; Tissue Array Analysis; Tunicamycin; Up-Regulation | 2015 |
Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.
Topics: Antioxidants; Breast Neoplasms; Cell Line, Tumor; Dehydroepiandrosterone; Deoxyglucose; Drug Synergism; Female; Glycolysis; Humans; Male; Oxidative Stress; Pentose Phosphate Pathway; Prostatic Neoplasms; Thioredoxins | 2015 |
Autophagy modulates the effects of bis-anthracycline WP631 on p53-deficient prostate cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Deoxyglucose; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Gene Expression; Humans; Male; Membrane Proteins; Microtubule-Associated Proteins; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Sequestosome-1 Protein; Time Factors; Tumor Suppressor Protein p53 | 2015 |
The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells.
Topics: Antimetabolites; Autophagy; Blotting, Western; Cell Cycle; Cell Line, Tumor; Deoxyglucose; Drug Evaluation, Preclinical; Humans; Male; Microscopy, Confocal; Microtubule-Associated Proteins; Prostatic Neoplasms | 2015 |
Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy.
Topics: Adenocarcinoma; Algorithms; Antimetabolites; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Caspases; Cell Line, Tumor; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Deoxyglucose; Humans; Male; Membrane Proteins; Microtubule-Associated Proteins; Models, Biological; Nutrition Therapy; Prostatic Neoplasms; Starvation | 2008 |
2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Estrenes; Female; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2008 |
Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.
Topics: Adenosine Triphosphate; Adenylate Kinase; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Cell Cycle; Cell Line, Tumor; Cell Survival; Deoxyglucose; Drug Synergism; Humans; Male; Metformin; Prostatic Neoplasms; Tumor Suppressor Protein p53 | 2010 |
Pioglitazone modulates tumor cell metabolism and proliferation in multicellular tumor spheroids.
Topics: Cell Line, Tumor; Cell Proliferation; Chromans; Deoxyglucose; Humans; Hydrogen-Ion Concentration; Hypoglycemic Agents; Lactic Acid; Male; Pioglitazone; PPAR gamma; Prostatic Neoplasms; Spheroids, Cellular; Thiazolidinediones; Troglitazone | 2011 |
The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells.
Topics: AMP-Activated Protein Kinases; Antimetabolites; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Deoxyglucose; Drug Synergism; Humans; Hypoglycemic Agents; Male; Membrane Proteins; Metformin; Prostatic Neoplasms | 2010 |
The effect of normoxia and hypoxia on a prostate (PC-3) CD44/CD41 cell side fraction.
Topics: Arsenates; Cell Count; Cell Growth Processes; Cell Line, Tumor; Cyclic N-Oxides; Deoxyglucose; Humans; Hyaluronan Receptors; Hydrogen-Ion Concentration; Male; Neoplastic Stem Cells; Oxygen; Platelet Membrane Glycoprotein IIb; Prostatic Neoplasms | 2011 |
Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Decitabine; Deoxyglucose; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Humans; Male; Prostate; Prostatic Neoplasms; Transcriptional Activation | 2012 |
Chemical anoxia delays germ cell apoptosis in the human testis.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aged; Antimetabolites; Apoptosis; Blotting, Southern; Cell Hypoxia; Deoxyglucose; DNA Fragmentation; Glycolysis; Humans; Hydrogen Peroxide; In Situ Nick-End Labeling; In Vitro Techniques; Male; Microscopy, Electron; Middle Aged; Oxygen Consumption; Potassium Cyanide; Prostatic Neoplasms; Pyruvic Acid; Spermatozoa; Testis | 2003 |
Repression of thermotolerance in Dunning R3327 prostate carcinoma cells by 2-deoxy-glucose.
Topics: Adaptation, Physiological; Adenosine Triphosphate; Animals; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyglucose; Dose-Response Relationship, Drug; Energy Metabolism; Flow Cytometry; Heat-Shock Response; Hot Temperature; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Male; Prostatic Neoplasms; Rats | 2004 |
Effect of metabolic inhibitors on ATP and citrate content in PC3 prostate cancer cells.
Topics: Aconitate Hydratase; Adenosine Triphosphate; Antimetabolites; Cell Line, Tumor; Citric Acid; Deoxyglucose; Dinitrophenols; Enzyme Inhibitors; Fluoroacetates; Glycolysis; Humans; Male; Oligomycins; Oxygen Consumption; Prostatic Neoplasms; Zinc | 2007 |
2-Deoxyglucose combined with wild-type p53 overexpression enhances cytotoxicity in human prostate cancer cells via oxidative stress.
Topics: Antimetabolites; Blotting, Western; Catalase; Combined Modality Therapy; Deoxyglucose; Flow Cytometry; Gene Expression; Genetic Therapy; Glutathione; Glutathione Peroxidase; Humans; Male; Oxidative Stress; Prostatic Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2008 |
Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Deoxyglucose; Fluorodeoxyglucose F18; Gemcitabine; In Vitro Techniques; Male; Prostatic Neoplasms; Rats; Tomography, Emission-Computed; Tumor Cells, Cultured | 1994 |
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Contrast Media; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
[Cancer screening with whole-body FDG PET].
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Tomography, Emission-Computed | 1996 |
FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models.
Topics: Animals; Cell Division; Deoxyglucose; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glycolysis; Hexokinase; Male; Mammary Neoplasms, Experimental; Monosaccharide Transport Proteins; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tomography, Emission-Computed | 1994 |
PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Biological Transport; Deoxycytidine; Deoxyglucose; DNA, Neoplasm; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Male; Neoplasm Transplantation; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Ribonucleotide Reductases; Thymidine; Tomography, Emission-Computed; Tritium; Tumor Cells, Cultured | 1997 |
Positron emission tomography of a human prostate cancer xenograft: association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal.
Topics: Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Deoxyglucose; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prostatic Neoplasms; Tomography, Emission-Computed; Transplantation, Heterologous | 1998 |
Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose.
Topics: Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pelvis; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Urinary Bladder Neoplasms | 1999 |